Neurogene Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Neurogene Inc's ROI in the second quarter of 2026?
Neurogene Inc recorded a cumulative net loss of $-111 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -43.9%.

Within the Healthcare sector 439 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3012 to 3596.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-3.76 %	14.37 %	37.75 %	68.54 %	186.54 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	223	244	272	273	282
Return On Investment (TTM)	-43.9 %	-36.82 %	-32.03 %	-28.94 %	-32.09 %
NGNE's Overall Ranking	# 3596	# 3012	# 3131	# 2277	# 2804
Seq. Investment Change TTM	-5.51 %	-5.05 %	-4.11 %	11.86 %	12.29 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-111	-99	-90	-85	-84

NGNE Company Profile >> Back to NGNE Roi Comparisons >> See Annual NGNE Return On Investment

Return On Investment NGNE's Ranking
Within:	No.
Industry	# 176
Sector	# 440
Overall	# 3596

Return On Investment Statistics
High	Average	Low
-17.95 %	-55.68 %	-508.97 %
(Sep 30 2020)		(Mar 31 2024)

Financial Statements
Neurogene Inc's II. Quarter Investments	$ 223 Millions	NGNE's Balance sheet
Neurogene Inc's II. Quarter Income	$ -34 Millions	Quarterly NGNE's Income Statement
NGNE's Income by Division		See NGNE's Income by Division

NGNE Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	272	321	200	105	155
Y / Y Investment Growth	-15.09 %	60.61 %	90.3 %	-32.17 %	-23.69 %
Net Income in Millions	-90	-75	-36	-58	-61
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-33.19 %	-23.44 %	-18.19 %	-54.88 %	-39.25 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NGNE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NGNE's Competitors
Subscribers only: Roi for Neurogene Inc's Suppliers
Subscribers only: Return On Investment for NGNE's Customers

Other Ratios
NGNE's Roa	NGNE's Inventory Turnover Ratio	NGNE's Growth Rates	NGNE's Dividend Statistics
	NGNE's Profitability Ratios	NGNE's Asset Turnover Ratio	NGNE's Dividend Growth
NGNE's Roe	NGNE's Valuation Ratios	NGNE's Financial Strength Ratios	NGNE's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:08:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.